Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

被引:11
|
作者
Poynter, Jenny N. [1 ,2 ]
Langholz, Bryan [2 ]
Largent, Joan [3 ]
Mellemkjaer, Lene [4 ]
Bernstein, Leslie [5 ]
Malone, Kathleen E. [6 ]
Lynch, Charles F. [7 ]
Borg, Ake [8 ]
Concannon, Patrick [9 ,10 ]
Teraoka, Sharon N. [9 ,10 ]
Xue, Shanyan [2 ]
Diep, Anh T. [2 ]
Torngren, Therese [8 ]
Begg, Colin B. [11 ]
Capanu, Marinela [11 ]
Haile, Robert W. [2 ]
Bernstein, Jonine L. [11 ]
机构
[1] Univ Minnesota, Div Pediat Epidemiol & Clin Res, Minneapolis, MN 55455 USA
[2] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA
[3] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA
[4] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark
[5] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA
[6] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[7] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[8] Lund Univ, Dept Oncol, Lund, Sweden
[9] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA
[10] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA
[11] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
Contralateral breast cancer; BRCA1; BRCA2; Reproductive factors; ESTROGEN-RECEPTOR; AGE; CARRIERS; PHENOTYPE; MENARCHE; COHORT; WOMEN; GENE;
D O I
10.1007/s10552-010-9510-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reproductive factors, such as early age at menarche, late age at menopause, and nulliparity are known risk factors for breast cancer. Previously, we reported these factors to be associated with risk of developing contralateral breast cancer (CBC). In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers. The WECARE Study is a population-based multi-center case-control study of 705 women with CBC (cases) and 1,397 women with unilateral breast cancer (controls). All participants were screened for BRCA1/2 mutations and 181 carriers were identified. Conditional logistic regression models were used to evaluate associations between reproductive factors and CBC for mutation carriers and non-carriers. None of the associations between reproductive factors and CBC risk differed between mutation carriers and non-carriers. The increase in risk with younger age at menarche and decrease in risk in women with more than two full-term pregnancies seen in non-carriers were not significantly different in carriers (adjusted RRs = 1.31, 95% CI 0.65-2.65 and 0.53, 95% CI 0.19-1.51, respectively). No significant associations between the other reproductive factors and CBC risk were observed in mutation carriers or non-carriers. For two reproductive factors previously shown to be associated with CBC risk, we observed similar associations for BRCA1/2 carriers. This suggests that reproductive variables that affect CBC risk may have similar effects in mutation carriers and non-carriers.
引用
收藏
页码:839 / 846
页数:8
相关论文
共 50 条
  • [31] Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Oden, Lovisa
    Akbari, Mohammad
    Zaman, Tasnim
    Singer, Christian F.
    Sun, Ping
    Narod, Steven A.
    Salmena, Leonardo
    Kotsopoulos, Joanne
    ONCOTARGET, 2016, 7 (52) : 86687 - 86694
  • [32] Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Kotsopoulos, Joanne
    Huzarski, Tomasz
    Gronwald, Jacek
    Singer, Christian F.
    Moller, Pal
    Lynch, Henry T.
    Armel, Susan
    Karlan, Beth
    Foulkes, William D.
    Neuhausen, Susan L.
    Senter, Leigha
    Tung, Nadine
    Weitzel, Jeffrey N.
    Eisen, Andrea
    Metcalfe, Kelly
    Eng, Charis
    Pal, Tuya
    Evans, Gareth
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [33] Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
    Reding, Kerryn W.
    Bernstein, Jonine L.
    Langholz, Bryan M.
    Bernstein, Leslie
    Haile, Robert W.
    Begg, Colin B.
    Lynch, Charles F.
    Concannon, Patrick
    Borg, Ake
    Teraoka, Sharon N.
    Torngren, Therese
    Diep, Anh
    Xue, Shanyan
    Bertelsen, Lisbeth
    Liang, Xiaolin
    Reiner, Anne S.
    Capanu, Marinela
    Malone, Kathleen E.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (02) : 491 - 498
  • [34] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
  • [35] Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study
    Segev, Yakir
    Rosen, Barry
    Lubinski, Jan
    Gronwald, Jacek
    Lynch, Henry T.
    Moller, Pal
    Kim-Sing, Charmaine
    Ghadirian, Parviz
    Karlan, Beth
    Eng, Charis
    Gilchrist, Dawna
    Neuhausen, Susan L.
    Eisen, Andrea
    Friedman, Eitan
    Euhus, David
    Ping, Sun
    Narod, Steven A.
    FAMILIAL CANCER, 2015, 14 (03) : 383 - 391
  • [36] Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Krammer, Julia
    Pinker-Domenig, Katja
    Robson, Mark E.
    Gonen, Mithat
    Bernard-Davila, Blanca
    Morris, Elizabeth A.
    Mangino, Debra A.
    Jochelson, Maxine S.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 565 - 571
  • [37] Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers
    Dennis, Jessica
    Ghadirian, Parviz
    Little, Julian
    Lubinski, Jan
    Gronwald, Jacek
    Kim-Sing, Charmaine
    Foulkes, William
    Moller, Pal
    Lynch, Henry T.
    Neuhausen, Susan L.
    Domchek, Susan
    Armel, Susan
    Isaacs, Claudine
    Tung, Nadine
    Sweet, Kevin
    Ainsworth, Peter
    Sun, Ping
    Krewski, Daniel
    Narod, Steven
    BREAST, 2010, 19 (06) : 479 - 483
  • [38] Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer
    Guzman-Arocho, Yaileen D.
    Rosenberg, Shoshana M.
    Garber, Judy E.
    Vardeh, Hilde
    Poorvu, Philip D.
    Ruddy, Kathryn J.
    Kirkner, Gregory
    Snow, Craig
    Tamimi, Rulla M.
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia F.
    Come, Steven E.
    Brachtel, Elena F.
    Marotti, Jonathan D.
    Warner, Ellen
    Partridge, Ann H.
    Collins, Laura C.
    BRITISH JOURNAL OF CANCER, 2022, 126 (02) : 302 - 309
  • [39] Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
    van der Kolk, Dorina M.
    de Bock, Geertruida H.
    Leegte, Beike K.
    Schaapveld, Michael
    Mourits, Marian J. E.
    de Vries, Jakob
    van der Hout, Annemieke H.
    Oosterwijk, Jan C.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 643 - 651
  • [40] Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Gronwald, Jacek
    Cybulski, Cezary
    Demsky, Rochelle
    Neuhausen, Susan L.
    Kim-Sing, Charmaine
    Tung, Nadine
    Friedman, Susan
    Senter, Leigha
    Weitzel, Jeffrey
    Karlan, Beth
    Moller, Pal
    Sun, Ping
    Narod, Steven A.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (05) : 1136 - 1146